A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease.

Saved in:
Bibliographic Details
Title: A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease.
Authors: Steinfield, Sara R.1 (AUTHOR), Stenn, Daniel F.1,2 (AUTHOR), Chen, Helen1,2 (AUTHOR), Kalisch, Bettina E.1,2 (AUTHOR) bkalisch@uoguelph.ca
Source: Pharmaceuticals (14248247). May2025, Vol. 18 Issue 5, p659. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph18050659